A citation-based method for searching scientific literature

Andrew M Tager, Peter LaCamera, Barry S Shea, Gabriele S Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy Polosukhin, John Wain, Banu A Karimi-Shah, Nancy D Kim, William K Hart, Annie Pardo, Timothy S Blackwell, Yan Xu, Jerold Chun, Andrew D Luster. Nat Med 2008
Times Cited: 480







List of co-cited articles
1206 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


LPA receptor signaling: pharmacology, physiology, and pathophysiology.
Yun C Yung, Nicole C Stoddard, Jerold Chun. J Lipid Res 2014
351
26

Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.
Nikos Oikonomou, Marios-Angelos Mouratis, Argyris Tzouvelekis, Eleanna Kaffe, Christos Valavanis, George Vilaras, Andreas Karameris, Glenn D Prestwich, Demosthenes Bouros, Vassilis Aidinis. Am J Respir Cell Mol Biol 2012
139
25

Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Toby M Maher, Ellen M van der Aar, Olivier Van de Steen, Lisa Allamassey, Julie Desrivot, Sonia Dupont, Liesbeth Fagard, Paul Ford, Ann Fieuw, Wim Wuyts. Lancet Respir Med 2018
99
24

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.
Scott M Palmer, Laurie Snyder, Jamie L Todd, Benjamin Soule, Rose Christian, Kevin Anstrom, Yi Luo, Robert Gagnon, Glenn Rosen. Chest 2018
53
45

LPA receptors: subtypes and biological actions.
Ji Woong Choi, Deron R Herr, Kyoko Noguchi, Yun C Yung, Chang-Wook Lee, Tetsuji Mutoh, Mu-En Lin, Siew T Teo, Kristine E Park, Alycia N Mosley,[...]. Annu Rev Pharmacol Toxicol 2010
564
17

A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.
J S Swaney, C Chapman, L D Correa, K J Stebbins, R A Bundey, P C Prodanovich, P Fagan, C S Baccei, A M Santini, J H Hutchinson,[...]. Br J Pharmacol 2010
151
16

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
16

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
Laurens A van Meeteren, Paula Ruurs, Catelijne Stortelers, Peter Bouwman, Marga A van Rooijen, Jean Philippe Pradère, Trevor R Pettit, Michael J O Wakelam, Jean Sébastien Saulnier-Blache, Christine L Mummery,[...]. Mol Cell Biol 2006
395
16

Autotaxin in Pathophysiology and Pulmonary Fibrosis.
Ioanna Ninou, Christiana Magkrioti, Vassilis Aidinis. Front Med (Lausanne) 2018
32
50

Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.
Yutong Zhao, Viswanathan Natarajan. Biochim Biophys Acta 2013
81
18

LPA1 receptor activation promotes renal interstitial fibrosis.
Jean-Philippe Pradère, Julie Klein, Sandra Grès, Charlotte Guigné, Eric Neau, Philippe Valet, Denis Calise, Jerold Chun, Jean-Loup Bascands, Jean-Sébastien Saulnier-Blache,[...]. J Am Soc Nephrol 2007
154
15

Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
Flavia V Castelino, Jon Seiders, Gretchen Bain, Sarah F Brooks, Christopher D King, James S Swaney, Daniel S Lorrain, Jerold Chun, Andrew D Luster, Andrew M Tager. Arthritis Rheum 2011
110
15

Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Makiko Umezu-Goto, Yasuhiro Kishi, Akitsu Taira, Kotaro Hama, Naoshi Dohmae, Koji Takio, Takao Yamori, Gordon B Mills, Keizo Inoue, Junken Aoki,[...]. J Cell Biol 2002
703
14

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
14

Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.
Masayuki Tanaka, Shinichi Okudaira, Yasuhiro Kishi, Ryunosuke Ohkawa, Sachiko Iseki, Masato Ota, Sumihare Noji, Yutaka Yatomi, Junken Aoki, Hiroyuki Arai. J Biol Chem 2006
339
14


The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Manuela Funke, Zhenwen Zhao, Yan Xu, Jerold Chun, Andrew M Tager. Am J Respir Cell Mol Biol 2012
77
16

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2).
Toby M Maher, Michael Kreuter, David J Lederer, Kevin K Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi-Saab,[...]. BMJ Open Respir Res 2019
38
34

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
12

Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
Katharine E Black, Evgeny Berdyshev, Gretchen Bain, Flavia V Castelino, Barry S Shea, Clemens K Probst, Benjamin A Fontaine, Irina Bronova, Lance Goulet, David Lagares,[...]. FASEB J 2016
28
42

Lysophospholipid receptors in drug discovery.
Yasuyuki Kihara, Hirotaka Mizuno, Jerold Chun. Exp Cell Res 2015
130
12

Two pathways for lysophosphatidic acid production.
Junken Aoki, Asuka Inoue, Shinichi Okudaira. Biochim Biophys Acta 2008
288
12

Blockade of lysophosphatidic acid receptors LPAR1/3 ameliorates lung fibrosis induced by irradiation.
Lu Gan, Jian-Xin Xue, Xin Li, De-Song Liu, Yan Ge, Pei-Yan Ni, Lin Deng, You Lu, Wei Jiang. Biochem Biophys Res Commun 2011
50
22

Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.
Akira Tokumura, Eiji Majima, Yuko Kariya, Kyoko Tominaga, Kentaro Kogure, Katsuhiko Yasuda, Kenji Fukuzawa. J Biol Chem 2002
541
10

An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Flavia V Castelino, Gretchen Bain, Veronica A Pace, Katharine E Black, Leaya George, Clemens K Probst, Lance Goulet, Robert Lafyatis, Andrew M Tager. Arthritis Rheumatol 2016
42
23

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
854
10

Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Ganesh Raghu, Bernt van den Blink, Mark J Hamblin, A Whitney Brown, Jeffrey A Golden, Lawrence A Ho, Marlies S Wijsenbeek, Martina Vasakova, Alberto Pesci, Danielle E Antin-Ozerkis,[...]. JAMA 2018
80
12

Lysophosphatidic acid as a lipid mediator with multiple biological actions.
Shizu Aikawa, Takafumi Hashimoto, Kuniyuki Kano, Junken Aoki. J Biochem 2015
126
10

Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior.
J J Contos, N Fukushima, J A Weiner, D Kaushal, J Chun. Proc Natl Acad Sci U S A 2000
382
10

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
10

Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
Ioanna Ninou, Eleanna Kaffe, Stefan Müller, David C Budd, Christopher S Stevenson, Christoph Ullmer, Vassilis Aidinis. Pulm Pharmacol Ther 2018
20
50

Lysophospholipid receptor nomenclature review: IUPHAR Review 8.
Yasuyuki Kihara, Michael Maceyka, Sarah Spiegel, Jerold Chun. Br J Pharmacol 2014
178
10


Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.
Yannick Allanore, Oliver Distler, Alexandre Jagerschmidt, Stephane Illiano, Laetitia Ledein, Eric Boitier, Inoncent Agueusop, Christopher P Denton, Dinesh Khanna. Arthritis Rheumatol 2018
35
28


Structural basis of substrate discrimination and integrin binding by autotaxin.
Jens Hausmann, Satwik Kamtekar, Evangelos Christodoulou, Jacqueline E Day, Tao Wu, Zachary Fulkerson, Harald M H G Albers, Laurens A van Meeteren, Anna J S Houben, Leonie van Zeijl,[...]. Nat Struct Mol Biol 2011
177
9

Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
Long Shuang Huang, Panfeng Fu, Priya Patel, Anantha Harijith, Tianjiao Sun, Yutong Zhao, Joe G N Garcia, Jerold Chun, Viswanathan Natarajan. Am J Respir Cell Mol Biol 2013
51
17

Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.
Aikaterini Nikolaou, Ioanna Ninou, Maroula G Kokotou, Eleanna Kaffe, Antreas Afantitis, Vassilis Aidinis, George Kokotos. J Med Chem 2018
17
52

Mechanisms of fibrosis: therapeutic translation for fibrotic disease.
Thomas A Wynn, Thirumalai R Ramalingam. Nat Med 2012
9

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.
Carlo Vancheri, Michael Kreuter, Luca Richeldi, Christopher J Ryerson, Dominique Valeyre, Jan C Grutters, Sabrina Wiebe, Wibke Stansen, Manuel Quaresma, Susanne Stowasser,[...]. Am J Respir Crit Care Med 2018
97
9

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy.
Bernt van den Blink, Marlous R Dillingh, Leo C Ginns, Lake D Morrison, Matthijs Moerland, Marlies Wijsenbeek, Elizabeth G Trehu, Brian J Bartholmai, Jacobus Burggraaf. Eur Respir J 2016
44
20


Autotaxin: structure-function and signaling.
Anastassis Perrakis, Wouter H Moolenaar. J Lipid Res 2014
86
10

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis.
Sydney B Montesi, Susan K Mathai, Laura N Brenner, Irina A Gorshkova, Evgeny V Berdyshev, Andrew M Tager, Barry S Shea. BMC Pulm Med 2014
29
31

Regulation and biological activities of the autotaxin-LPA axis.
Laurens A van Meeteren, Wouter H Moolenaar. Prog Lipid Res 2007
262
9

Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.
Gye Young Park, Yong Gyu Lee, Evgeny Berdyshev, Sharmilee Nyenhuis, Jian Du, Panfeng Fu, Irina A Gorshkova, Yongchao Li, Sangwoon Chung, Manjula Karpurapu,[...]. Am J Respir Crit Care Med 2013
78
11

Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
Matthew G K Benesch, Yuan Y Zhao, Jonathan M Curtis, Todd P W McMullen, David N Brindley. J Lipid Res 2015
66
13

LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.
Norihiko Sakai, Jerold Chun, Jeremy S Duffield, Takashi Wada, Andrew D Luster, Andrew M Tager. FASEB J 2013
97
9

Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.
Makoto Inoue, Md Harunor Rashid, Ryousuke Fujita, James J A Contos, Jerold Chun, Hiroshi Ueda. Nat Med 2004
384
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.